Reisfeld Rafael
The Center for Hyperhidrosis, Los Angeles, CA 90035, USA.
Clin Auton Res. 2006 Dec;16(6):384-9. doi: 10.1007/s10286-006-0374-z. Epub 2006 Nov 2.
Endoscopic thoracic sympathectomy is routinely used to treat severe hyperhidrosis. It is usually performed at the T2-T3 level of the nerve, but may produce less severe compensatory hidrosis if performed at a lower level. This study evaluates the outcome of 1,274 patients who underwent endoscopic thoracic sympathectomy for plamar, plantar, axillary or facial hyperhidrosis/blushing. Half of the patients were clamped at the T2-T3 level and half were clamped at the T3-T4 level. Postsurgical symptoms and side effects were assessed by interview. All of patients with palmar hyperhidrosis were cured or improved. Patients with plantar and axillary hyperhidrosis were more likely to be improved at T3-T4 level clamping. Patients with facial hyperhidrosis were more likely to be cured at T2-T3 level, but did show improvement at the T3-T4 level. Overall satisfaction was higher in the T3-T4 group. Some degree of mild compensatory sweating occurred in all patients. However, severe compensatory sweating was more common in the T2-T3 group. Around 2% of patients requested a reversal of their surgery. Endoscopic thoracic sympathectomy is a safe and effective treatment for hyperhidrosis. Clamping at the T3-T4 level has a more successful outcome. In particular, it appears to reduce the incidence of severe compensatory hidrosis.
内镜下胸交感神经切断术常用于治疗严重多汗症。该手术通常在T2 - T3神经节水平进行,但在较低水平进行手术可能会产生较轻的代偿性多汗。本研究评估了1274例因手掌、足底、腋窝或面部多汗症/脸红而接受内镜下胸交感神经切断术患者的治疗结果。一半患者在T2 - T3水平进行夹闭,另一半在T3 - T4水平进行夹闭。通过访谈评估术后症状和副作用。所有手掌多汗症患者均治愈或症状改善。足底和腋窝多汗症患者在T3 - T4水平夹闭时更易改善。面部多汗症患者在T2 - T3水平夹闭时更易治愈,但在T3 - T4水平夹闭时也有改善。T3 - T4组总体满意度更高。所有患者均出现一定程度的轻度代偿性出汗。然而,严重代偿性出汗在T2 - T3组更为常见。约2%的患者要求手术复原。内镜下胸交感神经切断术是治疗多汗症的一种安全有效的方法。在T3 - T4水平夹闭手术效果更佳。特别是,似乎能降低严重代偿性多汗的发生率。